LCN2 and metabolic dysfunction-associated steatotic liver disease: The role of this lipocalin as a biomarker seems very straightforward since independent research have implied LCN2 levels as a diagnostic tool to differentiate several stages of NAFLD as well as HCC from the previous tool.